Description

Lead the Lab. Grow the Business. Advance Public Health.
Are you a science-minded leader with a head for business and a heart for mission?  We are seeking a bold and capable Business Unit Manager to oversee our Microbiology laboratory in New Berlin, WI.

You’ll own the strategy, performance, and culture of a unit responsible for providing microbiological testing for clients. The testing portfolio includes analytical services to detect pathogenic microbes and other toxins. This is your chance to scale a business, lead a team, and make a difference!

What You’ll Do

• Set the Vision: Define and execute a strategy that positions EML - New Berlin as a leader in microbiology testing.
• Own Business Performance: Drive unit-level performance with full P&L accountability, budgeting, forecasting, and resource planning.
• Lead the Team: Manage, inspire, and develop scientists, analysts, and support staff in a collaborative, fast-moving environment.
• Elevate the Work: Ensure scientific integrity, operational excellence, and regulatory compliance.
• Engage Clients: Oversee key accounts, support business development, and represent the unit externally with confidence.

Qualifications

Your Background

• Education:
  • Bachelor’s in Microbiology, biology, food science, or related field preferred
  • Advanced degree (MBA, MS, or PhD) is a plus
• Leadership Experience:
  • 5+ years leading teams in a scientific or regulated environment
  • Proven success managing change, growth, or turnaround efforts
  • Skilled in team development, culture-building, and goal setting
• Technical Knowledge:
  • Working knowledge of Microbiological testing preferred
  • Understanding of regulatory standards (FDA, EPA, USDA) and lab operations helpful
• Business Acumen:
  • Experience managing budgets, KPIs, and operational metrics
  • Confident with business planning, client proposals, and capital decisions
  • Entrepreneurial mindset with strong follow-through

Additional Info

Why Eurofins?

Eurofins is a global leader in analytical testing, with 62,000+ employees across 900 labs. Our New Berlin  site plays a critical role in microbial testing. You’ll join a mission-driven team that values integrity, innovation, and impact—and you’ll have real ownership to grow the business.

Eurofins is a M/F, Disabled, and Veteran Equal Employment Opportunity and Affirmative Action employer.

All your information will be kept confidential according to EEO guidelines.

Eurofins USA Food Testing is a Disabled and Veteran Equal Employment Opportunity employer.

Company Description

Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins laboratories work with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.

The Eurofins network of companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leaders in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in biopharma contract development and manufacturing. It also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.

In over 35 years, Eurofins has grown from one laboratory in Nantes, France to ca. 63,000 staff across a decentralised and entrepreneurial network of more than 950 laboratories in 60 countries. Eurofins companies offer a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products.

In 2024, Eurofins generated total revenues of EUR 6,515 million, and has been among the best performing stocks in Europe over the past 20 years.